CLEVELAND, Jan. 24, 2011 /PRNewswire/ — Athersys, Inc. (Nasdaq:
ATHX), a clinical stage biopharmaceutical company, today
announced that its January 11th Retail Investor Conferences.com
presentation is available for on-demand viewing. Gil Van
Bokkelen, PhD, Chairman and Chief Executive Officer of Athersys,
presented to retail investors through the virtual investor
conference platform.
To view the archived presentation, click on www.retailinvestorconferences.com.
The Company’s presentation will be available for 30 days.
Investors may download shareholder materials from the “virtual
trade booth” for the next three weeks.
About Athersys
Athersys is a clinical stage biopharmaceutical company engaged
in the discovery and development of therapeutic product candidates
designed to extend and enhance the quality of human life. The
Company is developing MultiStem®, a patented, adult-derived
“off-the-shelf” stem cell product platform for multiple disease
indications, including damage caused by myocardial infarction, bone
marrow transplantation and oncology treatment support, ischemic
stroke, and inflammatory bowel disease. The Company is also
developing a portfolio of other therapeutic programs, including
orally active pharmaceutical product candidates for the treatment
of metabolic and central nervous system disorders, utilizing
proprietary technologies, including Random Activation of Gene
Expression (RAGE®). Athersys has forged several key
strategic alliances and collaborations with leading pharmaceutical
and biotechnology companies, as well as world-renowned research
institutions in the United States and Europe to further develop its
platform and products. More information is available at www.athersys.com.
About Retail
‘/>”/>
SOURCE